文献速递脑血管病认知障碍与痴呆

蒙特利尔认知评估筛查卒中后早期神经认知障碍的准确性:Nor-COAST研究

Test Accuracy of the Montreal Cognitive Assessment in Screening for Early Poststroke Neurocognitive Disorder: The Nor-COAST Study.
PubMed 文献 · Stroke · 2020-11-30

本研究为前瞻性观察研究,纳入卒中后3个月能完成认知测试组套和MoCA的连续参与者,以DSM-5标准定义卒中后神经认知障碍。共521名参与者,MoCA诊断神经认知障碍的ROC曲线下面积为0.80(95%CI 0.76-0.84);标准界值<26时敏感度0.71、特异度0.73,界值<27时敏感度0.82、特异度0.60。

要点

  • MoCA筛查卒中后神经认知障碍的AUC为0.80,具有合理准确性。
  • 标准界值<26时敏感度0.71、特异度0.73。
  • 界值<27可提高敏感度至0.82,但特异度降至0.60。

核心结论

  • MoCA对依据DSM-5标准诊断的卒中后神经认知障碍具有合理的筛查准确性。

研究设计与样本

  • 前瞻性观察研究,纳入卒中后3个月能完成认知测试组套和MoCA的连续参与者521名。

主要发现

  • MoCA诊断神经认知障碍的ROC曲线下面积为0.80(95%CI 0.76-0.84)。
  • MoCA界值<26时敏感度0.71(95%CI 0.69-0.79),特异度0.73(95%CI 0.66-0.76)。
  • MoCA界值<27时敏感度0.82(95%CI 0.77-0.85),特异度0.60(95%CI 0.53-0.66)。

关键数值与推荐

  • 神经认知障碍参考标准为认知测试组套中≥1个认知域得分低于常模均值≥1.5 SD。
  • 参与者平均年龄71.5岁(SD 12.0),平均教育年限12.4年(SD 3.8),女性占43.6%。

临床怎么用

  • MoCA可用于卒中后3个月神经认知障碍的筛查,界值<26时平衡敏感度与特异度,界值<27可提高敏感度但增加假阳性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: We determined the diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for poststroke neurocognitive disorder defined according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria in a prospective observational study. METHODS: Consecutive participants able to complete a cognitive test battery and MoCA 3 months poststroke were included. The reference standard of neurocognitive disorder was defined as a score of ≥1.5 SD below the normative mean in ≥1 cognitive domain on the cognitive test battery. RESULTS: Among 521 participants (43.6% women; mean age/SD, 71.5/12.0 years; mean education/SD, 12.4/3.8 years), the area under the receiver operating characteristic curve of MoCA for neurocognitive disorder was 0.80 (95% CI, 0.76-0.84). Using the standard MoCA cutoff <26, sensitivity was 0.71 (0.69-0.79) with specificity of 0.73 (0.66-0.76). MoCA cutoff of <27 gave higher sensitivity (0.82 [0.77-0.85]) at the expense of specificity (0.60 [0.53-0.66]). DISCUSSION: MoCA has reasonable accuracy for poststroke neurocognitive disorder diagnosed using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02650531.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Munthe-Kaas R, Aam S, Saltvedt I, et al. Test Accuracy of the Montreal Cognitive Assessment in Screening for Early Poststroke Neurocognitive Disorder: The Nor-COAST Study. Stroke. 2020. PMID: 33250039. doi:10.1161/STROKEAHA.120.031030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。